You are here:

Home
NICE Guidance
Conditions and diseases
Neurological conditions
Multiple sclerosis

Multiple sclerosis Products

A list of all our products on multiple sclerosis

Filter

Product type

Product typeGuidanceQuality standardsAdvice

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidanceInterventional procedures guidance

Status
1 selected

StatusPublishedIn developmentAwaiting developmentTopic selection

New and updated

New and updatedNew in the last 6 months

Showing 2 products

Sort by: Date | Sort by Title

Status: In developmentRemove ‘Status: In development’ filter

Natalizumab (originator and biosimilar) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy [ID6369]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Tolebrutinib for treating non-relapsing secondary progressive multiple sclerosis ID6351
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC